In 2025, Medicare beneficiaries will pay no more than $2,000 out of pocket for prescription drugs covered under Part D, Medicare’s outpatient drug benefit. This is due to a provision…
More than sixty-five million people ages 65 and older and younger people with long-term disabilities receive their health insurance coverage through the federal Medicare program. While overall satisfaction with the…
Under the Inflation Reduction Act, the federal government for the first time will negotiate directly with drug companies to determine the prices that Medicare will pay for certain high expenditure…
In 2021, 12.9 million people received health coverage through both the Medicare and Medicaid programs. For those “dual-eligible individuals,” Medicare is the primary payer and covers medical acute and post-acute…
For the first time in Medicare’s history, more than half of all eligible people with Medicare, or 30.8 million people in 2023, are enrolled in private Medicare Advantage plans. Medicare…
At Elephant Insurance, it’s not just our name that sets us apart from other insurance companies. We believe our core values of transparency, control, and value make us different. Those…
On January 5, 2024, the FDA authorized the state of Florida to import certain prescription drugs from Canada, an approach designed to give Floridians access to lower drug prices paid…
A new KFF policy watch explains some of the hurdles the state of Florida still must clear before it can implement its novel plan to make some prescription drugs more…
In September 2023, the Centers for Medicare and Medicaid Services (CMS) announced a new opportunity for states to leverage federal funding on health care: the Advancing All-Payer Health Equity Approaches…
Here’s a look back at 10 issues KFF tracked closely this year with some of our top findings summarized: Health care costs continue to be a burden for many Americans:…
